Lv3
230 积分 2025-07-05 加入
Management of Cutaneous Immune-Related Adverse Events in Patients With Cancer Treated With Immune Checkpoint Inhibitors
17天前
已完结
Dermatological Adverse Events Associated with Immune Checkpoint Inhibitor-Based Combinations of Anticancer Therapies: A Systematic Review
18天前
已完结
Narrative Medicine
1个月前
已完结
Peritumoural adipose tissue protects colorectal cancer from immune attack
1个月前
已完结
Peritumoural adipose tissue protects colorectal cancer from immune attack
1个月前
已完结
Obesity-driven inflammation and cancer risk: A comprehensive review
1个月前
已完结
Peritumoural adipose tissue drives immune evasion in colorectal cancer via adipose–mesenchymal transformation
1个月前
已完结
Phase II Study of Pembrolizumab Plus Capecitabine and Bevacizumab for Microsatellite Stable/Mismatch Repair-Proficient Metastatic Colorectal Cancer
2个月前
已完结
Neoadjuvant PD-1 blockade with sintilimab in mismatch-repair deficient, locally advanced rectal cancer: an open-label, single-centre phase 2 study
2个月前
已完结
Lipids guide T cell antitumor immunity by shaping their metabolic and functional fitness
2个月前
已完结
皖公网安备34019202002308
